FDG-PET/CT in Evaluation of Cytological Indeterminate Thyroid Nodules to Prevent Unnecessary Surgery (EfFECTS)
NCT02208544 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 132
Last updated 2022-05-04
Summary
The purpose of this study is to determine whether the use of molecular imaging using FDG-PET/CT could prevent unnecessary diagnostic thyroid surgery in case of indeterminate cytology during fine-needle aspiration biopsy.
Conditions
- Thyroid Nodule
- Thyroid Neoplasms
Interventions
- PROCEDURE
-
Diagnostic Thyroid Surgery
Diagnostic Thyroid Surgery
- DEVICE
-
Ultrasound of the head and neck
Confirmatory Neck Ultrasonography in FDG-PET/CT negative patient in the experimental arm
- RADIATION
-
FDG-PET/CT
Head and Neck FDG-PET/CT
Sponsors & Collaborators
-
Dutch Cancer Society
collaborator OTHER -
Radboud University Medical Center
lead OTHER
Principal Investigators
-
Lioe-Fee de Geus-Oei, MD, PhD · Leiden University Medical Center, Leiden, the Netherlands
-
Dennis Vriens, MD, PhD · Leiden University Medical Center, Leiden, the Netherlands
-
Lisanne de Koster, MD · Radboud University Medical Centre, Nijmegen, the Netherlands
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-07-16
- Primary Completion
- 2020-01-01
- Completion
- 2022-02-15
Countries
- Netherlands
Study Locations
More Related Trials
-
Diagnostic Value of 18F-Choline PET/CT in Patients With a Thyroid Nodule With an Indeterminate Cytology: Pilot Study
NCT02784223 ·Status: COMPLETED ·Phase: NA
-
Diagnostic Significance of FDG PET/CT Dynamic Imaging in Detecting Metastatic Lymph Nodes With Papillary Thyroid Cancer.
NCT03830242 ·Status: UNKNOWN ·Phase: NA
-
PET/CT Imaging of Angiogenesis in Lung or Head and Neck Cancers Prior or During Chemotherapy With Antiangiogenic Agents
NCT02325349 ·Status: TERMINATED ·Phase: PHASE2
-
68Ga-TCR-FAPI PET/CT Guided Precision Surgery for MTC
NCT06277180 ·Status: RECRUITING ·Phase: NA
-
Evaluation of 18F-FDOPA PET-CT in the Preoperative Initial Assessment of Medullary Thyroid Carcinoma
NCT03636945 ·Status: UNKNOWN ·Phase: NA
-
3'-Deoxy-3'-[18F] Fluorothymidine and Fludeoxyglucose F 18 PET Scans in Evaluating Response to Cetuximab, Cisplatin, and Radiation Therapy in Patients With Advanced Cancer of the Oropharynx, Larynx, or Hypopharynx
NCT00757549 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Use of 18F-PSMA-11 PET for Detection of Lesions in Iodine Refractory Thyroid Cancers
NCT05175404 ·Status: COMPLETED ·Phase: PHASE2
-
Volumetric Parameter of 18F-FDG PET/CT in Characterizing Thyroid Incidentalomas
NCT07163806 ·Status: NOT_YET_RECRUITING
-
Thyroid Cancer and (FDG)PET/CT Scan
NCT04128631 ·Status: UNKNOWN
-
Clinical Evaluation of 18F-DOPA Positron Emission Tomography in Medullary Thyroid Cancer
NCT00647140 ·Status: TERMINATED ·Phase: PHASE2
-
Tumor Metabolism of Head and Neck Cancer in Patients Who Underwent Radiation Therapy Measured With F-18-FDG-PET
NCT00180245 ·Status: COMPLETED
-
Clinical Value of 18F-FCH PET in Localizing Parathyroid Lesions: Comparison With MIBI Scan.
NCT03555487 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Calculate the Radiation Dosimetry in Subjects With Head and Neck Cancer
NCT00245349 ·Status: COMPLETED
-
18F-FSPG PET/CT as a Non-Invasive Imaging Biomarker for Treatment Response to Chemoradiation in Esophageal Cancer
NCT06549413 ·Status: ACTIVE_NOT_RECRUITING
-
Positron Emission Tomography/Computed Tomography Scanning Before Surgery in Patients With Non-Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer, Esophageal Cancer, or Head and Neck Cancer
NCT01254591 ·Status: UNKNOWN ·Phase: NA
-
18F-FDG PET/CT Guided Reduced-dose Radiotherapy for Nasopharyngeal Carcinoma
NCT04813705 ·Status: RECRUITING ·Phase: PHASE2
-
Comparison DW-MRI vs FDG PET/CT in the Detection of Early Recurrence of Cervical Well-differentiated Thyroid Carcinoma
NCT02515084 ·Status: COMPLETED ·Phase: PHASE2
-
Standard and Delayed FDG PET/CT After Chemoradiation Therapy in Assessing Patients With Metastatic Head and Neck Squamous Cell Cancer
NCT03575949 ·Status: COMPLETED ·Phase: NA
-
Research on the Application of 68Ga-DOTA-CCK-FS PET/CT in MTC
NCT07138716 ·Status: RECRUITING ·Phase: NA
-
PET in Guiding Cervical Lymphadenectomy (ECTOP-2003)
NCT03244566 ·Status: COMPLETED
-
The Value of 68Ga-FAPI PET/CT in Detecting Recurrent and Metastatic Lesions in Patients with Thyroid Cancer After Surgery
NCT06800768 ·Status: RECRUITING
-
Comparison of I-124 PET/CT, F-18 FDG PET/CT & I-123 Whole Body Scintigraphy for Recurrent Thyroid CA
NCT00373711 ·Status: WITHDRAWN
-
Imaging Properties of PET Radiotracer [18F]3F-PHPG in Patients With Neuroendocrine Tumors
NCT04510311 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Positron Emission Tomography (PET) During Radio-chemotherapy to Treat Otorhinolaryngological Cancer
NCT02469922 ·Status: COMPLETED ·Phase: NA
-
Determination of Molecular Status, the Efficacy and Safety of Fluorodeoxyglucose in PET-CT Imaging
NCT04943211 ·Status: RECRUITING ·Phase: PHASE3